A National Study of the Chronic Disease Self-Management Program

NCT ID: NCT01845857

Last Updated: 2013-05-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1170 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-08-31

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This survey will address important research, practice, and policy questions: How does Chronic Disease Self-Management Program (CDSMP) impact participants' general health, their health behaviors, and their need for health care utilization? Who benefits most from the CDSMP program? Are predicted gains maintained over a six and twelve month period? Can critical clinical changes be seen for those who are diabetic?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A national survey of participant outcomes is important for documenting how the CDSMP program is impacting people with chronic diseases and influencing health care outcomes. This study will help bridge the research to practice gap and further our knowledge about the outcomes of evidence?based programs that are widely disseminated.

Investigators hope to learn the answers to the following questions for English and Spanish-speaking populations:

1. How does the CDSMP impact a person's general health?
2. Does the CDSMP increase the use of healthful behaviors?
3. Does the CDSMP impact health care utilization?
4. What are the characteristics of those who benefit from the CDSMP?
5. Can these benefits be maintained over 6 and 12 month periods?
6. For people with type 2 diabetes, and hemoglobin A1c be impacted by the CDSMP?

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 2 Chronic Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chronic Disease Self-Management Workshop

Longitudinal study of participants who take the CDSMP workshop

Group Type EXPERIMENTAL

Chronic Disease Self-Management Workshop

Intervention Type BEHAVIORAL

6 week, small group self-management workshop

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chronic Disease Self-Management Workshop

6 week, small group self-management workshop

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 or over
* Has a chronic health condition
* Attending a Chronic Disease Self-Management Workshop at a designated host site in the United states
* Speaks English or Spanish
* For blood test portion of study: have type 2 diabetes
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stanford University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kate Lorig

professor emertius

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kate R Lorig

Role: PRINCIPAL_INVESTIGATOR

Stanford University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Stanford University School of Medicine

Stanford, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Lorig KR, Ritter P, Stewart AL, Sobel DS, Brown BW Jr, Bandura A, Gonzalez VM, Laurent DD, Holman HR. Chronic disease self-management program: 2-year health status and health care utilization outcomes. Med Care. 2001 Nov;39(11):1217-23. doi: 10.1097/00005650-200111000-00008.

Reference Type BACKGROUND
PMID: 11606875 (View on PubMed)

Lorig KR, Ritter PL, Gonzalez VM. Hispanic chronic disease self-management: a randomized community-based outcome trial. Nurs Res. 2003 Nov-Dec;52(6):361-9. doi: 10.1097/00006199-200311000-00003.

Reference Type BACKGROUND
PMID: 14639082 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18933 IRB Protocol

Identifier Type: -

Identifier Source: secondary_id

SU-07212010-6585

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Comparison of the ASHC and CDSMP
NCT00207415 COMPLETED NA
Wellness Self-Management
NCT01676909 COMPLETED NA
CHANGE -it is About Life
NCT01585493 COMPLETED PHASE3
Groups for Regaining Our Wellbeing
NCT03058952 COMPLETED NA